31.28USD-0.18%Mkt Cap: 3.83B USDP/E: 18.08Last update: 2026-06-01
Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing medicines for patients living with rare diseases in the United States. It offers Firdapse for the tr…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap3.83B USD
Enterprise Value3.07B USD
Revenue (TTM)596.96M USD
Gross Profit501.74M USD
Net Income (TTM)214.33M USD
Revenue/Share4.874 USD
Last Price31.28 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees182
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS14888U1016
Valuation
P/E (Trailing)18.08
P/E (Forward)9.96
PEG—
EV/EBITDA10.03
EV/Revenue5.14
P/S6.40
P/B3.77
EPS (TTM)1.73
EPS (Forward)3.14
52W Range
19.0591% of range32.56
52W High32.56 USD
52W Low19.05 USD
Profitability
Gross Margin85.19%
Oper. Margin49.02%
EBITDA Margin51.23%
Profit Margin36.39%
ROE22.46%
ROA19.41%
Growth
Revenue Growth5.60%
Earnings Growth11.10%
Cash Flow & Leverage
Operating CF208.67M USD
CapEx (TTM)58.00K USD
FCF Margin28.78%
FCF Yield4.49%
Net Debt-753.18M USD
Net Debt/EBITDA-2.46
Balance Sheet
Debt/Equity0.00
Current Ratio7.10
Quick Ratio6.70
Book Value/Sh8.288 USD
Cash/Share6.176 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)32.60 USD
Target Range31.50 USD – 36.00 USD
# Analysts5
Ownership
Shares Out.122.38M
Float115.58M
Insiders5.57%
Institutions89.33%
Short Interest
Short Ratio2.3d
Short % Float7.00%
Short % Out.5.65%
Shares Short6.91M
Short (prev mo.)8.49M
Technical
SMA 5027.49 (+13.8%)
SMA 20023.61 (+32.5%)
Beta0.72
S&P 52W Chg27.94%
Avg Vol (30d)2.77M
Avg Vol (10d)2.76M
Technical Indicators
RSI (14)73.9
MACD1.0129
MACD Signal1.2007
MACD Hist.-0.1878
BB Upper32.41 USD
BB Middle30.93 USD
BB Lower29.45 USD
BB Width9.55%
ATR (14)0.4180 USD
Vol Ratio (20d)0.45x